186 related articles for article (PubMed ID: 18275903)
1. Disseminated adenovirus disease by multiple adenovirus serotypes following allogeneic hematopoietic stem cell transplantation.
Suzuki HI; Asai T; Okada K; Kazuyama Y; Takahashi T; Kanda Y; Chiba S; Kurokawa M
Biol Blood Marrow Transplant; 2008 Mar; 14(3):353-5. PubMed ID: 18275903
[No Abstract] [Full Text] [Related]
2. Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy?
Chakrabarti S; Collingham KE; Fegan CD; Pillay D; Milligan DW
Bone Marrow Transplant; 2000 Aug; 26(3):305-7. PubMed ID: 10967570
[TBL] [Abstract][Full Text] [Related]
3. Advances in the management of disseminated adenovirus disease in stem cell transplant recipients: impact of adenovirus load (DNAemia) testing.
Heim A
Expert Rev Anti Infect Ther; 2011 Nov; 9(11):943-5. PubMed ID: 22029510
[No Abstract] [Full Text] [Related]
4. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
6. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
[TBL] [Abstract][Full Text] [Related]
7. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation.
Kal HB; van Kempen-Harteveld ML
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1525. PubMed ID: 18022583
[No Abstract] [Full Text] [Related]
8. Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation.
Cheng YC; Saliba RM; Rondón G; Giralt SA; Lu KH; Bodurka DC; Gershenson DM; Champlin RE; Ueno NT
Haematologica; 2005 Dec; 90(12):1725-6. PubMed ID: 16330461
[TBL] [Abstract][Full Text] [Related]
9. Cold agglutinin disease associated with adenovirus infection after allogeneic bone marrow transplantation.
Mori T; Yamada Y; Aisa Y; Uemura T; Ishida A; Ikeda Y; Okamoto S
Bone Marrow Transplant; 2005 Aug; 36(3):263-4. PubMed ID: 15937504
[No Abstract] [Full Text] [Related]
10. [Diagnosis and treatment of 26 cases of adenovirus infection after allogeneic hematopoietic stem cell transplantation].
Zhou F; Chen SN; Wu DP; He XF
Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):302-307. PubMed ID: 37356999
[No Abstract] [Full Text] [Related]
11. Erythrocytosis after allogeneic hematopoietic stem cell transplantation.
Hino Y; Doki N; Kurosawa S; Yamamoto K; Sakaguchi M; Harada K; Ikegawa S; Shingai N; Hattori K; Senoo Y; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28247439
[No Abstract] [Full Text] [Related]
12. Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease.
Lim ZY; Ho AY; Abrahams S; Fensom A; Aldouri M; Pagliuca A; Shaw C; Mufti GJ
Bone Marrow Transplant; 2008 May; 41(9):831-2. PubMed ID: 18246117
[No Abstract] [Full Text] [Related]
13. Sustained remission of psoriasis vulgaris after allogeneic bone marrow transplantation.
Mori J; Kakihana K; Ohashi K
Br J Haematol; 2012 Oct; 159(2):121. PubMed ID: 22924739
[No Abstract] [Full Text] [Related]
14. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
[TBL] [Abstract][Full Text] [Related]
15. Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.
Okuda S; Terasako K; Oshima K; Sato M; Nakasone H; Kako S; Yamazaki R; Tanaka Y; Tanihara A; Higuchi T; Nishida J; Kanda Y
Am J Hematol; 2009 Mar; 84(3):167-9. PubMed ID: 19195036
[TBL] [Abstract][Full Text] [Related]
16. Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection.
Zandvliet ML; Falkenburg JH; van Liempt E; Veltrop-Duits LA; Lankester AC; Kalpoe JS; Kester MG; van der Steen DM; van Tol MJ; Willemze R; Guchelaar HJ; Schilham MW; Meij P
Haematologica; 2010 Nov; 95(11):1943-51. PubMed ID: 20562315
[TBL] [Abstract][Full Text] [Related]
17. Successful desensitization to trimethoprim-sulfamethoxazole after allogeneic haematopoietic stem cell transplantation: preliminary observations.
Soffritti S; Ricci G; Prete A; Rondelli R; Menna G; Pession A
Med Pediatr Oncol; 2003 Apr; 40(4):271-2. PubMed ID: 12555266
[No Abstract] [Full Text] [Related]
18. Focal nodular hyperplasia in pediatric allogeneic hematopoietic cell transplant: case series.
Anderson L; Gregg D; Margolis D; Casper J; Talano J
Bone Marrow Transplant; 2010 Aug; 45(8):1357-9. PubMed ID: 20140023
[No Abstract] [Full Text] [Related]
19. Sequential emergence of multiple adenovirus serotypes after pediatric stem cell transplantation.
Kroes AC; de Klerk EP; Lankester AC; Malipaard C; de Brouwer CS; Claas EC; Jol-van der Zijde EC; van Tol MJ
J Clin Virol; 2007 Apr; 38(4):341-7. PubMed ID: 17317293
[TBL] [Abstract][Full Text] [Related]
20. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
